- <![CDATA[Ibrutinib Monotherapy Yields Decade-Long Durable Efficacy in Across CLL Subtypes]]><![CDATA[Ibrutinib monotherapy produced durable efficacy over 10 years in patients with or without TP53-mutated chronic lymphocytic leukemia.]]>onclive · 2mo ago↗ source
- #ASGCT26: Encoded's gene therapy reduced seizures in Dravet syndromeA gene therapy designed by Encoded Therapeutics reduced seizures by 76% in children with Dravet syndrome, a severe neurodevelopmental disorder. The remarkable reduction was observed only in three…Endpoints · 2mo ago↗ source
- #ASGCT26 dispatch: In vivo CAR-T is everywhereBOSTON — Greetings from Boston, where I’ve been on the ground covering the American Society of Gene & Cell Therapy’s annual meeting all week. It’s a crucial moment for the field. Genetic medi…